An overview of CAR T-cell clinical trial activity to 2021
Author(s) -
Antonella Adami,
John Maher
Publication year - 2021
Publication title -
immunotherapy advances
Language(s) - English
Resource type - Journals
ISSN - 2732-4303
DOI - 10.1093/immadv/ltab004
Subject(s) - medicine
Summary Immunotherapy of cancer using chimeric antigen receptor-engineered T-cells has transformed the management of selected haematological malignancies, triggering intense clinical trial activity in this arena. This article summarises trial activity that has been published to date across the spectrum of haematological and solid tumour types.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom